Skip to content
Live Report from ASH:<br />Can Intensive Immunochemotherapy Cure Mantle Cell Lymphoma?

Live Report from ASH:<br />Can Intensive Immunochemotherapy Cure Mantle Cell Lymphoma?

Get the podcast

Christian Geisler CHRISTIAN GEISLER, Rigshospitalet, Copenhagen Mantle cell lymphoma, which was previously considered incurable, has apparently been cured in some patients on a phase II study. Derek T

The Audio Journal of Oncology
Christian Geisler

Christian Geisler

CHRISTIAN GEISLER, Rigshospitalet, CopenhagenMantle cell lymphoma, which was previously considered incurable, has apparently been cured in some patients on a phase II study. Derek Thorne got the details on the study – which featured an intensive immunochemotherapy approach – fromChristian Geislerof Rigshospitalet in Copenhagen.

LISTEN

Tags

celllymphomapatientpodcastpodcastingreportreportsstudy

Next in ASH 2007

All 11 interviews

Interview 5 of 11

Live Report from ASH:<br />Oblimersen Extends Survival in Chronic Lymphocytic Leukemia

Live Report from ASH:<br />Oblimersen Extends Survival in Chronic Lymphocytic Leukemia

Susan O’Brien SUSAN O’BRIEN, MD Anderson Cancer Center, Houston For patients with relapsed or refractory CLL, oblimersen extends survival when added to standard fludarabine/cyclophosphamid

10 December 2007

Related Episodes

Chimeric antigen receptor T-cell therapy: high remission rate in relapsed, refractory acute lymphoblastic leukemia

Chimeric antigen receptor T-cell therapy: high remission rate in relapsed, refractory acute lymphoblastic leukemia

NEW ORLEANS—High remission rates with extended survival are being achieved in patients who had failed all other therapies — including allogeneic stem cell transplantation — for their acute lymphoblast

19 Dec 2013
Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free Survival

Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free Survival

Treatment of advanced pancreatic islet cell tumors with sunitinib has doubled progression-free survival in patients whose options have been very limited up to now, according to French researchers repo

28 Jul 2009
Audio Journal of Oncology Volume 16 Number 11

Audio Journal of Oncology Volume 16 Number 11

Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology

3 Jun 2008